闪罐结合非索非那定治疗急性荨麻疹疗效观察及对炎症因子、免疫因子及变态反应水平的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R758.24

基金项目:

金华市中医药科学技术项目(2024LC09)


Observation on Curative Effect of Flash Cupping Combined with Fexofenadine on Acute Urticaria and Its Effects on Levels of Inflammatory Factors, Immune Factors, and Allergic Reactions
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察闪罐疗法联合非索非那定治疗急性荨麻疹的临床疗效及对炎性因子、免疫细胞及变态 反应水平的影响。方法:选取2023年10月—2024年10月兰溪市人民医院皮肤科门诊治疗的100例急性荨麻疹 患者,按随机数字表法分为对照组、研究组各50例。对照组口服盐酸非索非那定片治疗,研究组在对照组治 疗基础上行闪罐疗法。2组均治疗1周,比较2组临床疗效,以及治疗前后炎症因子[肿瘤坏死因子-α(TNF-α)、 白细胞介素-4 (IL-4)、白细胞介素-6 (IL-6)]、免疫因子[总免疫球蛋白E (tIgE)、分泌型免疫球蛋白 E(sIgE)、嗜酸性粒细胞阳离子蛋白(ECP)]、变态反应指标[活化T细胞趋化因子(CCL5)、单核细胞趋化 蛋白-1(MCP-1)] 水平的变化。结果:研究组总有效率为94.00%(47/50),对照组为82.00%(41/50),2组 比较,差异有统计学意义(P<0.05)。治疗后,2组血清TNF-α、IL-4、IL-6水平均较治疗前降低(P<0.05), 且研究组3项指标水平均低于对照组(P<0.05)。治疗后,2组tIgE、sIgE、ECP水平均较治疗前降低(P< 0.05),且研究组3 项指标水平均低于对照组(P<0.05)。治疗后,2 组CCL5、MCP-1 水平均较治疗前降 低(P<0.05),且研究组2项指标水平均低于对照组(P<0.05)。结论:闪罐疗法与非索非那定联合治疗急性 荨麻疹可有效减轻炎症反应和变态反应,改善机体免疫功能,从而提高临床疗效。

    Abstract:

    Abstract:Objective:To observe the clinical effect of flash cupping therapy combined with Fexofenadine in the treatment of acute urticaria and its effects on the levels of inflammatory factors,immune cells,and allergic reactions. Methods: A total of 100 cases of patients with acute urticaria who visited the dermatology outpatient clinic at Lanxi People´s Hospital from October 2023 to October 2024 were selected and divided into the control group and the study group according to the random number table method,with 50 cases in each group. The control group was given the oral administration of Fexofenadine Hydrochloride Tablets,and the study group was additionally treated with flash cupping therapy based on the treatment of the control group. Both groups were treated for one week. The changes in inflammatory factors [tumor necrosis factor- α (TNF-α), interleukin-4 (IL-4), interleukin-6 (IL-6)], immune factors [total immunoglobulin E (tIgE), secretory immunoglobulin E (sIgE), eosinophil cationic protein (ECP)], and allergic reaction indicators [chemokine ligand 5 (CCL5), monocyte chemoattractant protein-1 (MCP-1)] before and after treatment as well as the clinical effects were compared between the two groups. Results:The total effective rate in the study group was 94.00% (47/50), compared to 82.00% (41/50) in the control group, with a significant difference between the two groups (P<0.05). After treatment,the levels of TNF-α,IL-4,and IL-6 in serum in the two groups were reduced when compared with those before treatment (P<0.05),and the levels in the study group were lower than those in the control group (P<0.05). After treatment, the levels of tIgE, sIgE, and ECP in the two groups were decreased when compared with those before treatment (P<0.05),with the study group showing lower levels than the control group (P<0.05). After treatment, the levels of CCL5 and MCP-1 in the two groups were decreased when compared with those before treatment (P<0.05), and the study group had lower levels than the control group (P< 0.05). Conclusion:The combination of flash cupping therapy and Fexofenadine in the treatment of acute urticaria can effectively reduce inflammatory and allergic reactions,improve immune function,and thereby improve clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

王燕,宋霞璐,周增民.闪罐结合非索非那定治疗急性荨麻疹疗效观察及对炎症因子、免疫因子及变态反应水平的影响[J].新中医,2025,57(10):93-97

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-05-27
  • 出版日期:
文章二维码